News
12h
Clinical Trials Arena on MSNIsomorphic Labs prepares to launch trials for AI-designed drugsIn an interview with Fortune, Isomorphic Labs president Colin Murdoch shared that four years after its founding, the company ...
Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
Demis Hassabis, CEO of Google DeepMind, hinted Tuesday evening that Veo 3, Google’s latest video generating model, could ...
This story is part of the 2025 TIME100. Read Jennifer Doudna’s tribute to Demis Hassabis here. Demis Hassabis learned he had won the 2024 Nobel Prize in Chemistry just 20 minutes before the ...
Google DeepMind CEO Demis Hassabis, one of the only people in the world with a Nobel Prize for work on artificial intelligence, shares what's next for the world of AI.
There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...
Demis Hassabis, CEO of Google’s AI research arm DeepMind and a Nobel Prize laureate, isn’t too worried about an AI “jobpocalypse.”. Instead of fretting over AI replacing jobs, he’s ...
Tech CEOs are promising increasingly outlandish visions of the 2030s, powered by "superintelligence", but the reality is that ...
Tech leaders are divided on AI's job impact, with some concerned it'll take over jobs and spike unemployment, and others ...
I t’s a truism that, the more you learn, the more you realize how much you don’t know. That mentality holds in most traditional academic disciplines, where humility is a survival strategy that keeps ...
Meanwhile, tech giants like Amazon and Microsoft are slashing their workforce amid massive spending to build and deploy new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results